News, research & perspectives

Children are a third of the world's population and receive under 2% of digital health innovation investment. Forbes on why, and why the gap is an opening. John is quoted.

John and Dr. Janene Fuerch, a Stanford neonatologist and Director of Impact1, talk about John's path to becoming a pediatric-focused investor, the rationale for investing in pediatrics, and some of the challenges and opportunities in the sector.

Recap of CobiCure's first Impact Series event in New York on pediatric innovation. John joined a panel on the barriers to pediatric innovation and how capital can reach it.

Writeup of a panel on rare disease drug development as an investment area for family offices. John spoke on barriers in the pharmaceutical industry and why a new model for drug development is needed.

John's advice to founders on setting up a board early: what skills to look for, how big it should be, and how to run good meetings.

John and host Rich Mazzola of Project Medtech discuss Springhood's investment thesis and how it approaches early-stage companies.

John on the funding gap in child health innovation and what it takes to invest in the sector, drawing on 25 years in alternative investments.